How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation?

被引:23
|
作者
Saia, Francesco [1 ]
Marrozzini, Cinzia [1 ]
Dall'Ara, Gianni [1 ]
Russo, Vincenzo [2 ]
Martin-Suarez, Sofia [3 ]
Savini, Carlo [3 ]
Ortolani, Paolo [1 ]
Palmerini, Tullio [1 ]
Taglieri, Nevio [1 ]
Bordoni, Barbara [1 ]
Pilato, Emanuele [3 ]
Di Bartolomeo, Roberto [3 ]
Branzi, Angelo [1 ]
Marzocchi, Antonio [1 ]
机构
[1] Univ Bologna, Inst Cardiol, Policlin S Orsola Malpighi, I-40138 Bologna, Italy
[2] Univ Bologna, Cardiovasc Radiol Unit, Policlin S Orsola Malpighi, Cardiothoracovasc Dept, I-40138 Bologna, Italy
[3] Univ Bologna, Dept Cardiac Surg, Policlin S Orsola Malpighi, I-40138 Bologna, Italy
关键词
aortic valve stenosis; biologic prosthesis; cardiac surgery; percutaneous aortic balloon valvuloplasty; transcatheter; ELDERLY-PATIENTS; NATURAL-HISTORY; VALVULOPLASTY; REPLACEMENT; DISEASE; MANAGEMENT; PROSTHESIS; GUIDELINES; DECISION; ADULTS;
D O I
10.2459/JCM.0b013e328338940f
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We sought to assess what proportion of patients with severe symptomatic aortic stenosis who are excluded from cardiac surgery are eligible for transcatheter aortic valve implantation (TAVI). Methods Between July 2007 and December 2008, 98 patients with severe symptomatic aortic stenosis judged inoperable were referred to our institution for percutaneous aortic balloon valvuloplasty (PABV). They entered a screening for TAVI with the CoreValve Revalving System or the Edwards-Sapien valve, comprising general clinical evaluation, echocardiogram, coronary angiography, angiography and angio-CT scan of thoracic aorta and ilio-femoral axes. Results Mean patients' age was 82 +/- 7 years; the vast majority presented relevant comorbidities. Mortality risk predicted by the logistic European System for Cardiac Operative Risk Evaluation was on average 25.3 +/- 14.5%. Overall, 45 (45.9%) patients met the criteria for TAVI: 29.6% for percutaneous transfemoral access, 6.1% for trans-subclavian and 10.2% for transapical approaches. Reason for exclusion was severe noncardiac comorbidity in around half of the cases. PABV allowed re-classification of several patients with very poor left ejection fraction and severe mitral regurgitation. Among the 39 patients undergoing TAVI after the screening, in-hospital mortality was 3.7% for transfemoral and 0 for trans-subclavian and transapical approaches. Conclusions TAVI represents a viable therapeutic option for elderly patients with severe symptomatic aortic stenosis who are not candidates for surgical aortic valve replacement. However, presently less than half of them actually fulfil the criteria for these procedures. J Cardiovasc Med 11: 727-732 (C) 2010 Italian Federation of Cardiology.
引用
收藏
页码:727 / 732
页数:6
相关论文
共 50 条
  • [1] Medical management of symptomatic severe aortic stenosis in patients non-eligible for transcatheter aortic valve implantation
    Gabriela Silvia Gheorghe
    Andreea Simona Hodorogea
    Andrei Cristian Dan Gheorghe
    Ioan Tiberiu Nanea
    Ana Ciobanu
    Journal of Geriatric Cardiology, 2020, 17 (11) : 704 - 709
  • [2] Medical management of symptomatic severe aortic stenosis in patients non-eligible for transcatheter aortic valve implantation
    Gheorghe, Gabriela Silvia
    Hodorogea, Andreea Simona
    Gheorghe, Andrei Cristian Dan
    Nanea, Ioan Tiberiu
    Ciobanu, Ana
    JOURNAL OF GERIATRIC CARDIOLOGY, 2020, 17 (11) : 704 - 709
  • [3] Medical management of symptomatic severe aortic stenosis in patients non-eligible for transcatheter aortic valve implantation
    Gabriela Silvia Gheorghe
    Andreea Simona Hodorogea
    Andrei Cristian Dan Gheorghe
    Ioan Tiberiu Nanea
    Ana Ciobanu
    Journal of Geriatric Cardiology, 2020, 17 (11) : 704 - 709
  • [4] Impact of transcatheter aortic valve implantation in symptomatic patients with very severe aortic stenosis
    Karaduman, Bilge Duran
    Ayhan, Huseyin
    Keles, Telat
    Bozkurt, Engin
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2021, 49 (02): : 97 - 107
  • [5] Transcatheter aortic valve implantation in Jehovah's Witness patients with symptomatic severe aortic valve stenosis
    Buz, Semih
    Pasic, Miralem
    Unbehaun, Axel
    Hetzer, Roland
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2012, 15 (04) : 766 - 768
  • [6] Correlates and Causes of Death in Patients With Severe Symptomatic Aortic Stenosis Who Are Not Eligible to Participate in a Clinical Trial of Transcatheter Aortic Valve Implantation
    Ben-Dor, Itsik
    Pichard, Augusto D.
    Gonzalez, Manuel A.
    Weissman, Gaby
    Li, Yanlin
    Goldstein, Steven A.
    Okubagzi, Petros
    Syed, Asmir I.
    Maluenda, Gabriel
    Collins, Sara D.
    Delhaye, Cedric
    Wakabayashi, Kohei
    Gaglia, Michael A., Jr.
    Torguson, Rebecca
    Xue, Zhenyi
    Satler, Lowell F.
    Suddath, William O.
    Kent, Kenneth M.
    Lindsay, Joseph
    Waksman, Ron
    CIRCULATION, 2010, 122 (11) : S37 - S42
  • [7] Transcatheter aortic valve implantation for severe symptomatic aortic stenosis: results in patients with porcelain aorta
    Zahn, R.
    Schuler, G. C.
    Sievert, H.
    Erbel, R.
    Hambrecht, R.
    Nickenig, G.
    Hauptmann, K. E.
    Naber, C. H.
    Sack, S.
    Gerckens, U.
    EUROPEAN HEART JOURNAL, 2011, 32 : 900 - 900
  • [8] Current status of transcatheter aortic valve implantation (TAVI) for patients with severe symptomatic aortic stenosis
    Zahn, R.
    Bauer, T.
    Kilkowski, C.
    Werner, N.
    Zeymer, U.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (39) : 1957 - 1959
  • [9] THE IMPACT OF TRANSCATHETER AORTIC VALVE IMPLANTATION ON QUALITY OF LIFE OF PATIENTS WITH SEVERE SYMPTOMATIC AORTIC STENOSIS
    Bagur, R.
    Rodes-Cabau, J.
    De Larochelliere, R.
    Doyle, D.
    Pibarot, P.
    Poirier, P.
    Villeneuve, J.
    Bergeron, S.
    Cote, M.
    Gutierrez, M.
    Bertrand, O. F.
    Dumont, E.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 102D - 102D
  • [10] Reversal of cardiac damage in patients with symptomatic severe aortic stenosis following transcatheter aortic valve implantation: An echocardiographic study
    Chung, B. K.
    Chan, E. Z.
    Thien, L. K.
    Pang, I. X.
    Chan, D. S. T.
    Khor, H. K.
    Shu, F. E. P.
    Ling, H. S.
    Chow, H. B.
    Jong, Y. H.
    Soon, S. Y.
    Tan, C. T.
    Koh, K. T.
    Cham, Y. L.
    Said, A.
    Fong, A. Y. Y.
    Ong, T. K.
    Oon, Y. Y.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 369 : 2 - 2